NeurAxis (NRXS) Institutional Ownership $2.28 -0.03 (-1.09%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for NeurAxis (NASDAQ:NRXS)CurrentInstitutional OwnershipPercentage11.77%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$397.15KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$23.50K Get NRXS Insider Trade Alerts Want to know when executives and insiders are buying or selling NeurAxis stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NRXS Institutional Buying and Selling by Quarter NeurAxis Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/6/2025 AIGH Capital Management LLC19,869$43K0.0%N/A0.275% 2/17/2025 Citadel Advisors LLC47,094$111K0.0%N/A0.656% 2/13/2025 Bank of Montreal Can139,017$327K0.0%-6.7%1.936% 1/22/2025 Parsons Capital Management Inc. RI116,726$274K0.0%+797.9%1.672% 1/22/2024 Parsons Capital Management Inc. RI13,000$35K0.0%N/A0.246% (Data available from 1/1/2016 forward) NRXS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NRXS shares? During the previous two years, the following institutional investors and hedge funds held shares of NeurAxis shares: Bank of Montreal Can ($327K), Parsons Capital Management Inc. RI ($274K), and Citadel Advisors LLC ($111K), AIGH Capital Management LLC ($43K).Learn more on NRXS's institutional investors. What percentage of NeurAxis stock is owned by institutional investors? 11.77% of NeurAxis stock is owned by institutional investors. Learn more on NRXS's institutional investor holdings. Which institutional investors have been buying NeurAxis stock? The following institutional investors have purchased NeurAxis stock in the last 24 months: Parsons Capital Management Inc. RI ($116.73K), Citadel Advisors LLC ($47.09K), and AIGH Capital Management LLC ($19.87K). How much institutional buying is happening at NeurAxis? Institutional investors have bought a total of 183,689 shares in the last 24 months. This purchase volume represents approximately $431.86K in transactions. Which NeurAxis major shareholders have been selling company stock? The following institutional investors have sold NeurAxis stock in the last 24 months: Bank of Montreal Can ($10K). How much institutional selling is happening at NeurAxis? Institutional investors have sold a total of 10,000 shares in the last 24 months. This volume of shares sold represents approximately $23.50K in transactions. Related Companies InspireMD Major Shareholders Sensus Healthcare Major Shareholders Inovio Pharmaceuticals Major Shareholders Milestone Scientific Major Shareholders Vivani Medical Major Shareholders Carmell Major Shareholders Edap Tms Major Shareholders Hyperfine Major Shareholders Apyx Medical Major Shareholders Zynex Major Shareholders This page (NASDAQ:NRXS) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeurAxis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeurAxis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.